Company Filing History:
Years Active: 2023
Title: Innovations of Jung-Ae Lim in Biopharmaceuticals
Introduction
Jung-Ae Lim is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biopharmaceuticals, particularly in the preparation of compositions containing factor VIII and von Willebrand factor. Her innovative methods have the potential to enhance the efficiency of treatments for blood disorders.
Latest Patents
Jung-Ae Lim holds a patent for a method of preparing a composition containing factor VIII (FVIII) and von Willebrand factor (vWF) with controlled content of von Willebrand factor (vWF). This method allows for the controlled mixing of FVIII and vWF after their separate purification from plasma. The process is designed to minimize impurities and maintain the yield of FVIII while keeping the processing time within three hours.
Career Highlights
Jung-Ae Lim is associated with Green Cross Holdings Corporation, where she applies her expertise in biopharmaceutical research. Her work focuses on improving the quality and efficiency of therapeutic compositions, which is crucial for patients requiring factor VIII and vWF.
Collaborations
Jung-Ae Lim collaborates with esteemed colleagues such as Jee Won Ahn and Kwan Young Ko. These partnerships enhance the research and development efforts within her organization, fostering innovation in the biopharmaceutical sector.
Conclusion
Jung-Ae Lim's contributions to the field of biopharmaceuticals exemplify the impact of innovative methods in medical treatments. Her patent for the preparation of FVIII and vWF compositions showcases her commitment to advancing healthcare solutions.